More recently, Zhu et al. (2025) provided evidence for a pathway in which inflammation (IL-6) decreases mesolimbic dopamine in a cancer mouse model, and that apathy and depressive symptoms in the mice could be alleviated by blocking the IL-6 receptors in the brain (Zhu et al., 2025). The gene discussed is IL6; the disease is cancer.